The HH and Wnt pathways can jointly induce CSC biomarkers, such as CD44, CD133, BMI1, and LGR5, and promote EMT, thereby promoting tumor cell infiltration and distant metastasis and allowing tumor cells to obtain stem cell characteristics and drug resistance capacity (74). Here, CD44 is linked to neoplasm.